Companies / Slate Bio
Slate Bio
United States
Slate Bio develops advanced T reg therapy for autoimmune diseases
Slate Bio, based in United States, has 2 investors on file, among them Epidarex and UVA Licensing & Ventures Group. Its site turns away automated reads, so VCinfo could not check it; it is listed because an investor's own portfolio page links to it.
SEC Form D filings
3 filingsFiled by Slate Bio, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Investor |
More from Epidarex
25 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
More from UVA Licensing & Ventures Group
34 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (67%), Semiconductors & Electronics (12%), Education (12%).
See UVA Licensing & Ventures Group's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Slate Bio and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Epidarex adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/slatebio.com/investors
# also
GET /v1/companies/slatebio.com
GET /v1/companies/slatebio.com/news